Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across

The recent approval of messenger RNA (mRNA)-based vaccines to combat the SARS-CoV-2 pandemic highlights the potential of both conventional mRNA and self-amplifying mRNA (saRNA) as a flexible immunotherapy platform to treat infectious diseases. Besides the antigen it encodes, mRNA itself has an immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnaert, An-Katrien, Vanluchene, Helena, Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Raemdonck, Koen, Sanders, Niek N., Remaut, Katrien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325057/
https://www.ncbi.nlm.nih.gov/pubmed/34324884
http://dx.doi.org/10.1016/j.addr.2021.113900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325057/
https://www.ncbi.nlm.nih.gov/pubmed/34324884
http://dx.doi.org/10.1016/j.addr.2021.113900

Ejemplares similares